Category: Fragile X Syndrome

A college degree may protect against neurodegeneration in genetically at-risk populations

Obtaining a college degree may be protective against neurodegenerative symptoms in women with an elevated genetic risk.

New NIH grant to study language use as potential predictor of neurodegenerative disorder in FMR1 premutation carriers

A new study will investigate if language differences can predict the development of a neurodegenerative disorder in people that carry a premutation of the gene FMR1.

New Department of Defense grant to study fragile x syndrome in human cells

Xinyu Zhao, PhD, and Anita Bhattacharyya, PhD, will partner on research over the next four years to better understand the molecular underpinnings behind the diversity of FXS symptoms and how that diversity may inform the search for effective therapies.

Cancer drug may be treatment option for fragile X syndrome

A newer cancer drug may also be a treatment option for a leading intellectual and developmental disability. Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.

Celebrando los diez años de participación en investigación de la familia Manlick

English Pensamientos de gratitud: la familia Manlick Por Emily Leclerc, Escritora Científica, Waisman Center James Manlick irá al baile de bienvenida de la escuela este año y simplemente no puede contener su emoción. Una gran sonrisa ilumina su rostro mientras habla sobre el baile. Como estudiante de último año de la escuela secundaria, esta será …

Celebrating the Manlick family’s ten years of research participation

James Manlick is going to homecoming this year and he simply can’t contain his excitement. A huge smile lights up his face as he talks about the dance.

Schizophrenia: Illuminating a potential treatment and gene regulation

A new study from the lab of Waisman investigator Xinyu Zhao brings us one step closer to identifying treatments for psychiatric disorders like schizophrenia (SCZ) and illuminates the role of a specific gene in regulating the disorder.  

Artificial intelligence can accelerate clinical diagnosis of fragile X syndrome

An analysis of electronic health records for 1.7 million Wisconsin patients revealed a variety of health problems newly associated with fragile X syndrome.

Inside Waisman: Meet Lindsay McCary

As a third year graduate student in school psychology at the University of South Carolina, Lindsay McCary, PhD, was looking for a new advisor to help her with her dissertation.

Improved technique illuminates fragile X protein

Researchers at the Waisman Center made a significant step in understanding the function of a specific protein, FMR1, whose absence causes fragile X syndrome, or FXS. Waisman investigators Xinyu Zhao, PhD, and Anita Bhattacharyya, PhD, with research associate Meng Li, published their paper “Identification of FMR1-regulated molecular networks in human neurodevelopment” in the March issue of the journal Genome Research.